RH director Mark Demilio reduced his stake by selling 2,254 shares on January 14. He disposed of these shares at an average of 220 per share, generating proceeds of approximately 495,880. Following this transaction, his direct ownership stands at 19,962 shares, representing a 10.15 percent decrease in his holding. The sale was disclosed in an SEC filing, underscoring a rare instance of material insider liquidity in the company’s common stock.

In the quarter ended December 11, RH reported revenue of 883.81 million, up 8.9 percent year-over-year and essentially flat with consensus estimates. However, earnings per share came in at 1.71, missing the analyst consensus of 2.13 by 0.42. The net margin was 3.22 percent, while return on equity was negative 161.72 percent, reflecting elevated leverage with a debt-to-equity ratio north of 900 percent. Analysts forecast full-year EPS of 4.39 and are watching for margin improvement as a catalyst for multiple expansion.

Wall Street sentiment is split. Morgan Stanley upgraded its target to 275, highlighting intact revenue growth and potential for a re-rating, while Goldman Sachs cut its target to 144 and assigned a sell recommendation. Other firms range from overweight to underperform, with the consensus price target near 227 based on nine buy, eight hold and four sell ratings. Institutional activity has likewise been varied, with large fund purchases and disposals that may amplify near-term trading volatility without providing a clear directional signal for RH’s fundamentals.